BTEC garners 3 new NIIMBL projects

Published Jan. 23, 2019

BTEC is participating in three of 22 projects recently funded by The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL). NIIMBL, a Manufacturing USA institute designed to advance biopharmaceutical manufacturing in the United States, selected 14 technology and 8 workforce development projects from those submitted in response to its Project Call 2.1. That project call solicited projects addressing key technology and workforce priority areas defined by industry members. Working in conjunction with industry partners and other universities, BTEC will engage in the following projects:

  • Development of a Microchip CE_HPMS Analyzer for Bioreactor Monitoring – Dr. Ryan Barton, automation/data scientist at BTEC, will contribute to this project.
  • Online Lyophilization Short Course – BTEC Acting Director Gary Gilleskie will participate in this project.
  • Biopharmaceutical Manufacturing for the FDA – Patty Brown, senior instructional designer at BTEC, will assist with this project.

In addition, BTEC leads two NIIMBL projects and participates in three others that were funded in earlier project calls. Those projects include the development of a scalable platform process for the production, purification and analysis of adeno-associated virus (AAV) vectors used in gene therapy; implementing automated test beds; and investigating methods to identify, characterize and remove host-cell proteins.

The 22 new projects recently announced by NIIMBL have an approximate value of nearly $13M, including NIIMBL funding and cost share from participating organizations. The NIIMBL portfolio now includes a total investment of more than $45M across 44 technology and workforce development projects. Project teams represent industry partners, leading research institutions, community colleges, and non-profits.


NIIMBL is a public-private partnership with the goal of advancing innovation in biopharmaceutical manufacturing. NIIMBL is part of Manufacturing USA®, a network of 14 manufacturing institutes across the country that brings together industry, academia, and the public sector to propel promising research developments, accelerate new products to market, and train tomorrow’s workforce in order to secure America’s future. NIIMBL is funded through a cooperative agreement with the National Institute of Standards and Technology (NIST) in the U.S. Department of Commerce, and leverages additional support from industry, academic institutions, non-profit organizations, and the states of Delaware, Maryland, North Carolina, and the Commonwealth of Massachusetts. The NIIMBL mission is to accelerate biopharmaceutical innovation, support the development of standards that enable more efficient and rapid manufacturing capabilities, and educate and train a world-leading biopharmaceutical manufacturing workforce, fundamentally advancing U.S. competitiveness in this industry.